Trial Outcomes & Findings for Endostapler Hemostasis Study (NCT NCT04149925)
NCT ID: NCT04149925
Last Updated: 2021-02-23
Results Overview
Intraoperative staple line bleeding as measured by the provided bleeding severity scale (1: No bleeding; 2: Minimal bleeding; 3: Moderate bleeding; 4: Excessive bleeding; 5: Profuse bleeding)
COMPLETED
60 participants
10 seconds after last staple line
2021-02-23
Participant Flow
Participant milestones
| Measure |
AEON Endostapler
Stapling performed by AEON Endostapler
AEON Endostapler: Surgery with AEON Endostapler
|
Echelon Flex Powered Stapler
Stapling performed by Echelon Flex Powered Stapler
Echelon Flex Powered Stapler: Surgery with Echelon Flex Powered Stapler
|
|---|---|---|
|
Overall Study
STARTED
|
30
|
30
|
|
Overall Study
COMPLETED
|
30
|
30
|
|
Overall Study
NOT COMPLETED
|
0
|
0
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Race and Ethnicity were not collected from any participant.
Baseline characteristics by cohort
| Measure |
AEON Endostapler
n=30 Participants
Stapling performed by AEON Endostapler
AEON Endostapler: Surgery with AEON Endostapler
|
Echelon Flex Powered Stapler
n=30 Participants
Stapling performed by Echelon Flex Powered Stapler
Echelon Flex Powered Stapler: Surgery with Echelon Flex Powered Stapler
|
Total
n=60 Participants
Total of all reporting groups
|
|---|---|---|---|
|
Age, Continuous
|
46 years
STANDARD_DEVIATION 11 • n=30 Participants
|
45 years
STANDARD_DEVIATION 11 • n=30 Participants
|
46 years
STANDARD_DEVIATION 11 • n=60 Participants
|
|
Sex: Female, Male
Female
|
18 Participants
n=30 Participants
|
25 Participants
n=30 Participants
|
43 Participants
n=60 Participants
|
|
Sex: Female, Male
Male
|
12 Participants
n=30 Participants
|
5 Participants
n=30 Participants
|
17 Participants
n=60 Participants
|
|
Race and Ethnicity Not Collected
|
—
|
—
|
0 Participants
Race and Ethnicity were not collected from any participant.
|
|
BMI
|
44 kg/m^2
STANDARD_DEVIATION 6 • n=30 Participants
|
46 kg/m^2
STANDARD_DEVIATION 7 • n=30 Participants
|
45 kg/m^2
STANDARD_DEVIATION 7 • n=60 Participants
|
PRIMARY outcome
Timeframe: 10 seconds after last staple lineIntraoperative staple line bleeding as measured by the provided bleeding severity scale (1: No bleeding; 2: Minimal bleeding; 3: Moderate bleeding; 4: Excessive bleeding; 5: Profuse bleeding)
Outcome measures
| Measure |
AEON Endostapler
n=30 Participants
Stapling performed by AEON Endostapler
AEON Endostapler: Surgery with AEON Endostapler
|
Echelon Flex Powered Stapler
n=30 Participants
Stapling performed by Echelon Flex Powered Stapler
Echelon Flex Powered Stapler: Surgery with Echelon Flex Powered Stapler
|
|---|---|---|
|
Staple Line Bleeding
|
2.08 score on a scale
Standard Deviation .98
|
2.57 score on a scale
Standard Deviation 1.13
|
SECONDARY outcome
Timeframe: 1 month following procedureIncidence of postoperative leakage during one-month monitoring period following procedure
Outcome measures
| Measure |
AEON Endostapler
n=30 Participants
Stapling performed by AEON Endostapler
AEON Endostapler: Surgery with AEON Endostapler
|
Echelon Flex Powered Stapler
n=30 Participants
Stapling performed by Echelon Flex Powered Stapler
Echelon Flex Powered Stapler: Surgery with Echelon Flex Powered Stapler
|
|---|---|---|
|
Staple Line Leaking
Yes
|
0 Participants
|
0 Participants
|
|
Staple Line Leaking
No
|
30 Participants
|
30 Participants
|
SECONDARY outcome
Timeframe: 1 month following procedureIncidence of reported device-related adverse events
Outcome measures
| Measure |
AEON Endostapler
n=30 Participants
Stapling performed by AEON Endostapler
AEON Endostapler: Surgery with AEON Endostapler
|
Echelon Flex Powered Stapler
n=30 Participants
Stapling performed by Echelon Flex Powered Stapler
Echelon Flex Powered Stapler: Surgery with Echelon Flex Powered Stapler
|
|---|---|---|
|
Adverse Events
Yes
|
0 Participants
|
0 Participants
|
|
Adverse Events
No
|
30 Participants
|
30 Participants
|
SECONDARY outcome
Timeframe: During surgeryIncidence of product malfunction during procedure
Outcome measures
| Measure |
AEON Endostapler
n=30 Participants
Stapling performed by AEON Endostapler
AEON Endostapler: Surgery with AEON Endostapler
|
Echelon Flex Powered Stapler
n=30 Participants
Stapling performed by Echelon Flex Powered Stapler
Echelon Flex Powered Stapler: Surgery with Echelon Flex Powered Stapler
|
|---|---|---|
|
Product Malfunction
Yes
|
0 Participants
|
0 Participants
|
|
Product Malfunction
No
|
30 Participants
|
30 Participants
|
SECONDARY outcome
Timeframe: Within 72 hours of surgery startIncidence of intraoperative or postoperative blood transfusion within 72 hours of surgery start time
Outcome measures
| Measure |
AEON Endostapler
n=30 Participants
Stapling performed by AEON Endostapler
AEON Endostapler: Surgery with AEON Endostapler
|
Echelon Flex Powered Stapler
n=30 Participants
Stapling performed by Echelon Flex Powered Stapler
Echelon Flex Powered Stapler: Surgery with Echelon Flex Powered Stapler
|
|---|---|---|
|
Blood Transfusion
Yes
|
0 Participants
|
0 Participants
|
|
Blood Transfusion
No
|
30 Participants
|
30 Participants
|
SECONDARY outcome
Timeframe: 1 week following procedurePostoperative pain level as measured by a standard pain severity scale of 0-10 where 0 means no pain and 10 means severe pain.
Outcome measures
| Measure |
AEON Endostapler
n=30 Participants
Stapling performed by AEON Endostapler
AEON Endostapler: Surgery with AEON Endostapler
|
Echelon Flex Powered Stapler
n=30 Participants
Stapling performed by Echelon Flex Powered Stapler
Echelon Flex Powered Stapler: Surgery with Echelon Flex Powered Stapler
|
|---|---|---|
|
Pain Level
|
1.8 score on a scale
Standard Deviation 2.9
|
1.6 score on a scale
Standard Deviation 2.7
|
Adverse Events
AEON Endostapler
Echelon Flex Powered Stapler
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place